We invite you to join our VP Sales & Marketing, Dr. Anil Berger, as speaker on this year’s Annual Meeting of the Japanese Society of Digital Pathology on Friday August 20th 2021, 15:00-16:00 JST. He will present data from our study on the robustness of our flagship AI-product BreastIHC against real-life image variability. Included were 200+ specimens balanced for clinical scores, prepared with 3 stainers, digitized on 5 scanners plus 1 microscope camera and evaluated by 10 pathologists with and without AI: Put to the test “in the wild” we show that BreastIHC works out-of-the-box in any laboratory setting.
It detects tumor cells on IHC-slides directly, then classifies them according to the relevant subgroups (per biomarker: Ki-67, ER, PR) and quantifies them in order to give the relevant clinical score(s) for each biomarker.
